| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | coumarin 7-hydroxylase activity | 1.29e-07 | 3 | 102 | 3 | GO:0008389 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 2.33e-07 | 27 | 102 | 5 | GO:0008391 | |
| GeneOntologyMolecularFunction | steroid hydroxylase activity | 7.79e-07 | 34 | 102 | 5 | GO:0008395 | |
| GeneOntologyMolecularFunction | aromatase activity | 9.06e-07 | 35 | 102 | 5 | GO:0070330 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 5.03e-06 | 49 | 102 | 5 | GO:0016712 | |
| GeneOntologyMolecularFunction | anandamide 8,9 epoxidase activity | 1.54e-04 | 4 | 102 | 2 | GO:0062187 | |
| GeneOntologyMolecularFunction | anandamide 11,12 epoxidase activity | 1.54e-04 | 4 | 102 | 2 | GO:0062188 | |
| GeneOntologyMolecularFunction | steroid 21-monooxygenase activity | 1.54e-04 | 4 | 102 | 2 | GO:0004509 | |
| GeneOntologyMolecularFunction | progesterone 21-hydroxylase activity | 1.54e-04 | 4 | 102 | 2 | GO:0106309 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 2.42e-04 | 24 | 102 | 3 | GO:0008392 | |
| GeneOntologyMolecularFunction | neuropilin binding | 2.56e-04 | 5 | 102 | 2 | GO:0038191 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 3.10e-04 | 115 | 102 | 5 | GO:0004497 | |
| GeneOntologyMolecularFunction | fatty acyl-CoA hydrolase activity | 3.46e-04 | 27 | 102 | 3 | GO:0047617 | |
| GeneOntologyMolecularFunction | anandamide 14,15 epoxidase activity | 3.82e-04 | 6 | 102 | 2 | GO:0062189 | |
| GeneOntologyMolecularFunction | anandamide epoxidase activity | 3.82e-04 | 6 | 102 | 2 | GO:0062186 | |
| GeneOntologyMolecularFunction | acyl-CoA hydrolase activity | 3.86e-04 | 28 | 102 | 3 | GO:0016289 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | HIC1 RARB ETV2 SOX18 TEAD1 SOX8 HMX1 EOMES BCL11B ZFHX4 ZNF398 TPRX1 IRX2 GLIS1 FOXD4 ZNF513 NPAS1 | 7.71e-04 | 1412 | 102 | 17 | GO:0000981 |
| GeneOntologyMolecularFunction | heme binding | 1.17e-03 | 154 | 102 | 5 | GO:0020037 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 1.54e-03 | 164 | 102 | 5 | GO:0046906 | |
| GeneOntologyMolecularFunction | iron ion binding | 1.63e-03 | 166 | 102 | 5 | GO:0005506 | |
| GeneOntologyMolecularFunction | thiolester hydrolase activity | 1.78e-03 | 47 | 102 | 3 | GO:0016790 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 1.11e-07 | 10 | 101 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 1.11e-07 | 10 | 101 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid metabolic process | 1.72e-07 | 124 | 101 | 8 | GO:0001676 | |
| GeneOntologyBiologicalProcess | regulation of sensory perception of pain | 4.46e-06 | 23 | 101 | 4 | GO:0051930 | |
| GeneOntologyBiologicalProcess | regulation of sensory perception | 5.34e-06 | 24 | 101 | 4 | GO:0051931 | |
| GeneOntologyBiologicalProcess | arachidonate metabolic process | 2.08e-05 | 68 | 101 | 5 | GO:0019369 | |
| GeneOntologyBiologicalProcess | saturated monocarboxylic acid metabolic process | 2.37e-05 | 2 | 101 | 2 | GO:0032788 | |
| GeneOntologyBiologicalProcess | unsaturated monocarboxylic acid metabolic process | 2.37e-05 | 2 | 101 | 2 | GO:0032789 | |
| GeneOntologyBiologicalProcess | long-chain fatty-acyl-CoA catabolic process | 7.10e-05 | 3 | 101 | 2 | GO:0036116 | |
| GeneOntologyBiologicalProcess | serotonin biosynthetic process from tryptophan | 7.10e-05 | 3 | 101 | 2 | GO:0006587 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | FIGNL2 ETV2 SOX18 TRIM71 TEAD1 SOX8 EOMES FMN1 ARMC5 PXN AJUBA IRX2 CRB2 | 7.50e-05 | 750 | 101 | 13 | GO:0048729 |
| GeneOntologyBiologicalProcess | positive regulation of protein-containing complex assembly | 1.28e-04 | 227 | 101 | 7 | GO:0031334 | |
| GeneOntologyBiologicalProcess | epoxygenase P450 pathway | 1.64e-04 | 22 | 101 | 3 | GO:0019373 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | HIC1 RARB ATN1 TRO SOX18 SOX8 HMX1 EOMES PRDM13 CTBP2 HDAC10 AJUBA IRX2 GLIS1 NPAS1 | 1.82e-04 | 1053 | 101 | 15 | GO:0000122 |
| GeneOntologyBiologicalProcess | secondary metabolic process | 3.28e-04 | 67 | 101 | 4 | GO:0019748 | |
| MousePheno | decreased intestinal cholesterol absorption | 2.85e-06 | 17 | 85 | 4 | MP:0002647 | |
| MousePheno | abnormal intestinal cholesterol absorption | 4.60e-06 | 19 | 85 | 4 | MP:0002645 | |
| MousePheno | abnormal intestinal lipid absorption | 3.53e-05 | 31 | 85 | 4 | MP:0005342 | |
| Domain | Cyt_P450_E_grp-I_CYP2A-like | 5.93e-07 | 4 | 100 | 3 | IPR008067 | |
| Domain | Bile_Hydr_Trans | 5.93e-07 | 4 | 100 | 3 | PF04775 | |
| Domain | Thio_Ohase/aa_AcTrfase | 5.93e-07 | 4 | 100 | 3 | IPR006862 | |
| Domain | Acyl-CoA_thioEstase_long-chain | 5.93e-07 | 4 | 100 | 3 | IPR016662 | |
| Domain | BAAT_C | 1.48e-06 | 5 | 100 | 3 | IPR014940 | |
| Domain | BAAT_C | 1.48e-06 | 5 | 100 | 3 | PF08840 | |
| Domain | Atrophin-like | 2.84e-05 | 2 | 100 | 2 | IPR002951 | |
| Domain | Atrophin-1 | 2.84e-05 | 2 | 100 | 2 | PF03154 | |
| Domain | SMR-like | 8.48e-05 | 3 | 100 | 2 | IPR026288 | |
| Domain | PROL5-SMR | 8.48e-05 | 3 | 100 | 2 | PF15621 | |
| Domain | Cyt_P450_E_grp-I | 9.74e-05 | 45 | 100 | 4 | IPR002401 | |
| Domain | Cyt_P450_CS | 1.85e-04 | 53 | 100 | 4 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 2.46e-04 | 57 | 100 | 4 | PS00086 | |
| Domain | - | 2.63e-04 | 58 | 100 | 4 | 1.10.630.10 | |
| Domain | p450 | 2.63e-04 | 58 | 100 | 4 | PF00067 | |
| Domain | Cyt_P450 | 3.00e-04 | 60 | 100 | 4 | IPR001128 | |
| Domain | Pectin_lyase_fold/virulence | 7.78e-04 | 8 | 100 | 2 | IPR011050 | |
| Domain | FH2 | 2.85e-03 | 15 | 100 | 2 | PS51444 | |
| Domain | FH2_Formin | 2.85e-03 | 15 | 100 | 2 | IPR015425 | |
| Domain | FH2 | 2.85e-03 | 15 | 100 | 2 | PF02181 | |
| Domain | FH2 | 2.85e-03 | 15 | 100 | 2 | SM00498 | |
| Domain | HMG_box | 2.87e-03 | 53 | 100 | 3 | PF00505 | |
| Domain | HMG_BOX_2 | 3.03e-03 | 54 | 100 | 3 | PS50118 | |
| Domain | HMG | 3.03e-03 | 54 | 100 | 3 | SM00398 | |
| Domain | - | 3.19e-03 | 55 | 100 | 3 | 1.10.30.10 | |
| Domain | HMG_box_dom | 5.12e-03 | 65 | 100 | 3 | IPR009071 | |
| Domain | Znf_C2H2_jaz | 6.11e-03 | 22 | 100 | 2 | IPR022755 | |
| Domain | zf-C2H2_jaz | 6.11e-03 | 22 | 100 | 2 | PF12171 | |
| Domain | G_patch | 6.67e-03 | 23 | 100 | 2 | SM00443 | |
| Domain | G_patch_dom | 6.67e-03 | 23 | 100 | 2 | IPR000467 | |
| Domain | ZnF_RBZ | 6.67e-03 | 23 | 100 | 2 | SM00547 | |
| Domain | G_PATCH | 6.67e-03 | 23 | 100 | 2 | PS50174 | |
| Domain | G-patch | 6.67e-03 | 23 | 100 | 2 | PF01585 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 2.01e-09 | 12 | 70 | 5 | MM14847 | |
| Pathway | REACTOME_FATTY_ACIDS | 2.13e-08 | 18 | 70 | 5 | MM14841 | |
| Pathway | REACTOME_XENOBIOTICS | 1.28e-07 | 25 | 70 | 5 | MM14846 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 1.79e-07 | 11 | 70 | 4 | M27130 | |
| Pathway | REACTOME_XENOBIOTICS | 4.60e-06 | 23 | 70 | 4 | M5372 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 1.85e-05 | 66 | 70 | 5 | MM14839 | |
| Pathway | REACTOME_FATTY_ACIDS | 5.11e-05 | 15 | 70 | 3 | M27126 | |
| Pathway | WP_MESODERMAL_COMMITMENT_PATHWAY | 1.10e-04 | 153 | 70 | 6 | M39546 | |
| Pathway | KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS | 1.69e-04 | 22 | 70 | 3 | M11673 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 1.72e-04 | 105 | 70 | 5 | MM14842 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_TO_DNA_ADDUCTS | 2.41e-04 | 5 | 70 | 2 | M47808 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 2.50e-04 | 62 | 70 | 4 | M39653 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 2.83e-04 | 64 | 70 | 4 | M5650 | |
| Pathway | WP_7OXOC_AND_7BETAHC_PATHWAYS | 3.15e-04 | 27 | 70 | 3 | M40054 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 4.45e-04 | 72 | 70 | 4 | M9257 | |
| Pubmed | 7.84e-11 | 4 | 105 | 4 | 7565685 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | HIC1 RARB ETV2 SOX18 ZNF385A TEAD1 SOX8 HMX1 EOMES BCL11B ZFHX4 ZNF398 TPRX1 RERE IRX2 GLIS1 FOXD4 NPAS1 | 2.56e-10 | 908 | 105 | 18 | 19274049 |
| Pubmed | 2.73e-09 | 7 | 105 | 4 | 9630227 | ||
| Pubmed | Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition. | 2.67e-08 | 3 | 105 | 3 | 31645370 | |
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 8297477 | ||
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 8188299 | ||
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 8250953 | ||
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 2703500 | ||
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 22217847 | ||
| Pubmed | Differential distribution of CYP2A6 and CYP2A13 in the human respiratory tract. | 2.67e-08 | 3 | 105 | 3 | 22890016 | |
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 3346244 | ||
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 2733794 | ||
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 10567408 | ||
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 8484736 | ||
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 1417950 | ||
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 24045421 | ||
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 32987105 | ||
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 2765478 | ||
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 2415518 | ||
| Pubmed | 1.04e-07 | 15 | 105 | 4 | 29968852 | ||
| Pubmed | 1.07e-07 | 4 | 105 | 3 | 10490589 | ||
| Pubmed | Two steroid 15 alpha-hydroxylase genes and a homologous gene family in mice. | 1.07e-07 | 4 | 105 | 3 | 1970547 | |
| Pubmed | 1.07e-07 | 4 | 105 | 3 | 15007068 | ||
| Pubmed | 1.07e-07 | 4 | 105 | 3 | 9408084 | ||
| Pubmed | 1.13e-07 | 263 | 105 | 9 | 20932939 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.19e-07 | 351 | 105 | 10 | 38297188 | |
| Pubmed | 1.81e-07 | 17 | 105 | 4 | 27197076 | ||
| Pubmed | Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. | 2.25e-07 | 44 | 105 | 5 | 12745259 | |
| Pubmed | 2.66e-07 | 5 | 105 | 3 | 16940157 | ||
| Pubmed | Molecular genetics of the human cytochrome P450 monooxygenase superfamily. | 3.66e-07 | 20 | 105 | 4 | 9890157 | |
| Pubmed | 5.31e-07 | 6 | 105 | 3 | 7668294 | ||
| Pubmed | 5.31e-07 | 6 | 105 | 3 | 8587134 | ||
| Pubmed | Mitochondrial phosphoproteome revealed by an improved IMAC method and MS/MS/MS. | 8.42e-07 | 57 | 105 | 5 | 17208939 | |
| Pubmed | 9.28e-07 | 7 | 105 | 3 | 14630516 | ||
| Pubmed | 2.22e-06 | 9 | 105 | 3 | 37838304 | ||
| Pubmed | A revised nomenclature for mammalian acyl-CoA thioesterases/hydrolases. | 2.22e-06 | 9 | 105 | 3 | 16103133 | |
| Pubmed | 2.36e-06 | 70 | 105 | 5 | 15128046 | ||
| Pubmed | BCL9L CPSF6 HMGXB4 ZNF385A GPATCH8 LGALS3 C6orf132 TAOK2 PRR12 SRRT PXN HELZ CTBP2 UNC93B1 ZNF598 EPN1 INO80E | 2.47e-06 | 1497 | 105 | 17 | 31527615 | |
| Pubmed | 5.77e-06 | 12 | 105 | 3 | 31116980 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 6.17e-06 | 544 | 105 | 10 | 28473536 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 12325023 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 30876690 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 21395539 | ||
| Pubmed | Species differences in coumarin metabolism: a molecular modelling evaluation of CYP2A interactions. | 9.03e-06 | 2 | 105 | 2 | 12162851 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 1302041 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 8395817 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 10814707 | ||
| Pubmed | Absence of cytochrome P450 2A5 enhances alcohol-induced liver injury in mice. | 9.03e-06 | 2 | 105 | 2 | 25804444 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 1520280 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 23917075 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 25808902 | ||
| Pubmed | CYP2A7 polymorphic alleles confound the genotyping of CYP2A6*4A allele. | 9.03e-06 | 2 | 105 | 2 | 16636685 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 27902773 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 11207030 | ||
| Pubmed | Circadian Regulation of Hepatic Cytochrome P450 2a5 by Peroxisome Proliferator-Activated Receptor γ. | 9.03e-06 | 2 | 105 | 2 | 30154104 | |
| Pubmed | Expression of CYP2A genes in human liver and extrahepatic tissues. | 9.03e-06 | 2 | 105 | 2 | 10353262 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 11330065 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 21418183 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 22700965 | ||
| Pubmed | Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. | 9.03e-06 | 2 | 105 | 2 | 3123997 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 19923441 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 12499123 | ||
| Pubmed | Function and regulation of the Cyp2a5/CYP2A6 genes in response to toxic insults in the liver. | 9.03e-06 | 2 | 105 | 2 | 22497566 | |
| Pubmed | The role of CYP2A5 in liver injury and fibrosis: chemical-specific difference. | 9.03e-06 | 2 | 105 | 2 | 26363552 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 2712571 | ||
| Pubmed | Characterization of Cyp2d22, a novel cytochrome P450 expressed in mouse mammary cells. | 9.03e-06 | 2 | 105 | 2 | 11032406 | |
| Pubmed | Evaluation of inhibition selectivity for human cytochrome P450 2A enzymes. | 9.03e-06 | 2 | 105 | 2 | 22696418 | |
| Pubmed | Nicotine enhances alcoholic fatty liver in mice: Role of CYP2A5. | 9.03e-06 | 2 | 105 | 2 | 30222954 | |
| Pubmed | Up-regulation of CYP2A5 expression by porphyrinogenic agents in mouse liver. | 9.03e-06 | 2 | 105 | 2 | 7543189 | |
| Pubmed | Characterization and regulation of sex-specific mouse steroid hydroxylase genes. | 9.03e-06 | 2 | 105 | 2 | 2372744 | |
| Pubmed | The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. | 9.03e-06 | 2 | 105 | 2 | 2322567 | |
| Pubmed | Acyl-CoA thioesterase-2 facilitates mitochondrial fatty acid oxidation in the liver. | 9.03e-06 | 2 | 105 | 2 | 25114170 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 21473878 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 7581481 | ||
| Pubmed | Expression and alternative splicing of the cytochrome P-450 CYP2A7. | 9.03e-06 | 2 | 105 | 2 | 7864805 | |
| Pubmed | Interstrain differences in the expression and activity of Cyp2a5 in the mouse liver. | 9.03e-06 | 2 | 105 | 2 | 28298240 | |
| Pubmed | Genetic polymorphisms for a phenobarbital-inducible cytochrome P-450 map to the Coh locus in mice. | 9.03e-06 | 2 | 105 | 2 | 6309775 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 22262919 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 25635819 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 19594327 | ||
| Pubmed | Coding-noncoding gene expression in intrahepatic cholangiocarcinoma. | 9.03e-06 | 2 | 105 | 2 | 26297049 | |
| Pubmed | Genetic variation between mice in their metabolism of coumarin and its derivatives. | 9.03e-06 | 2 | 105 | 2 | 566237 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 8611142 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 15051713 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 665441 | ||
| Pubmed | Essential role of the cytochrome P450 enzyme CYP2A5 in olfactory mucosal toxicity of naphthalene. | 9.03e-06 | 2 | 105 | 2 | 24104196 | |
| Pubmed | Novel DNA sequence variations of cytochrome P450 genes in the Han Chinese population. | 9.50e-06 | 14 | 105 | 3 | 19290787 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 1.06e-05 | 457 | 105 | 9 | 32344865 | |
| Pubmed | Yin Yang 1 sustains biosynthetic demands during brain development in a stage-specific manner. | 1.27e-05 | 47 | 105 | 4 | 31097699 | |
| Pubmed | 1.61e-05 | 608 | 105 | 10 | 16713569 | ||
| Pubmed | 2.50e-05 | 19 | 105 | 3 | 23968833 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 18068688 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 11960914 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 3219345 | ||
| Pubmed | Zfp30, a KRAB domain containing zinc finger protein gene, maps to mouse chromosome 7. | 2.70e-05 | 3 | 105 | 2 | 7849402 | |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 20840855 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 30417565 | ||
| Pubmed | Cutting Edge: Divergent Requirement of T-Box Transcription Factors in Effector and Memory NK Cells. | 2.70e-05 | 3 | 105 | 2 | 29440505 | |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 35215835 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 1973143 | ||
| Interaction | CYP2A7 interactions | 1.26e-07 | 3 | 102 | 3 | int:CYP2A7 | |
| Interaction | EGR2 interactions | 2.54e-06 | 171 | 102 | 8 | int:EGR2 | |
| Interaction | TLE3 interactions | BCL9L ATN1 TEAD1 GPATCH8 PRR12 SRRT BCL11B HELZ CTBP2 RERE VCP | 3.22e-06 | 376 | 102 | 11 | int:TLE3 |
| Interaction | CYP2A6 interactions | 1.03e-05 | 9 | 102 | 3 | int:CYP2A6 | |
| Interaction | ALG13 interactions | 4.05e-05 | 183 | 102 | 7 | int:ALG13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | CYP2A6 CYP2A7 CYP2A13 ETV2 GRIN2D PRR12 ALDH16A1 TPRX1 EPN1 LTBP4 ARHGAP33 NPAS1 | 1.89e-05 | 1192 | 105 | 12 | chr19q13 |
| Cytoband | 19q13.33 | 1.07e-04 | 106 | 105 | 4 | 19q13.33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q13 | 9.99e-04 | 330 | 105 | 5 | chr22q13 | |
| Cytoband | 22q13.1 | 1.00e-03 | 85 | 105 | 3 | 22q13.1 | |
| Cytoband | 14q24.3 | 1.30e-03 | 93 | 105 | 3 | 14q24.3 | |
| GeneFamily | Cytochrome P450 family 2 | 3.16e-07 | 35 | 75 | 5 | 1001 | |
| GeneFamily | Acyl-CoA thioesterases | 8.06e-06 | 10 | 75 | 3 | 41 | |
| Coexpression | WENG_POR_DOSAGE | 1.18e-07 | 30 | 104 | 5 | MM1199 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-06 | 175 | 105 | 6 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | facs-Heart|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-06 | 197 | 105 | 6 | 6a9571c0a3238b39214afdece93d7541bc8a0a70 | |
| ToppCell | LPS_only-Myeloid-Monocytes,_Macrophages-Erythroid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.97e-05 | 139 | 105 | 5 | d96e5c17582f1576fa09d6bad35c418b6248448c | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.50e-05 | 146 | 105 | 5 | 447c05414eda71681a0c07baba900f88ed6165ed | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.75e-05 | 149 | 105 | 5 | 65778f19599b4955c0a16f0121237656449431fb | |
| ToppCell | Healthy_donor-B_cell|World / disease group, cell group and cell class (v2) | 2.84e-05 | 150 | 105 | 5 | a2dfed562de7f58f902b547acec5a13853c80c4c | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.54e-05 | 157 | 105 | 5 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-05 | 162 | 105 | 5 | 0321fc954ae4ad67ca438cbbc84632562d222188 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-05 | 162 | 105 | 5 | 5731f9514434296132df4bc86f78ce87b07cdeca | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Igfbp2)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.26e-05 | 82 | 105 | 4 | 89aff8676f98e062d0e69b38c7184e51aa1a915e | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Igfbp2)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.26e-05 | 82 | 105 | 4 | 6875a10abf1221b3dfd954c319b5e8e12fac1ff2 | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Igfbp2)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.26e-05 | 82 | 105 | 4 | 259bb4ae0373d8352cb1c3bff08f66b89a298440 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.46e-05 | 172 | 105 | 5 | ef33b5e0515c6d29fb6d9a673011c1b68ef264f3 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.09e-05 | 176 | 105 | 5 | c4d9166e5bbb7ca544107db14e4374289f5de6bd | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Endothelial-kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.09e-05 | 176 | 105 | 5 | d58ef51002ea50b3037636038214bbb7454cb503 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.43e-05 | 178 | 105 | 5 | c7e890cd02206c516cf1d7692ea7abc8ce746482 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.43e-05 | 178 | 105 | 5 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | 3'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct-SMG_duct_L.0.6.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.60e-05 | 179 | 105 | 5 | ec331b1132f965581f851a3b29e62873c4140e6c | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_NK-T_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.77e-05 | 180 | 105 | 5 | 0a98d21fec67a890e75ebf0e2d23adddd77da214 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.77e-05 | 180 | 105 | 5 | 1c8398342d3fa4d5ca9a8a63626cc497c5291446 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_NK-T_NK-CD56_bright_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.77e-05 | 180 | 105 | 5 | ddbab26b05f057bd78b78773381cd447bd2e2726 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.77e-05 | 180 | 105 | 5 | b6efdb4d319ef6f87f559acd974e5a71b06a2322 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-05 | 181 | 105 | 5 | 4df7972f88117108698efd06b124b232f8588981 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-05 | 181 | 105 | 5 | cbb530566893281289026bfd93adf721decd4ca3 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 7.32e-05 | 183 | 105 | 5 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | Control-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 7.71e-05 | 185 | 105 | 5 | 0af540323c0113203ba6c1a4cb32d2fb9cf79d39 | |
| ToppCell | droplet-Skin|droplet / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.71e-05 | 185 | 105 | 5 | 657fd191ed160f8620d57b33820ec7222806f289 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-05 | 186 | 105 | 5 | 37860daeecd6d412bd3797f30496a56da667fbd1 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-05 | 186 | 105 | 5 | 60830822d3de3147816693404fd03392e04c2b8e | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-05 | 186 | 105 | 5 | baebeffdd426ce767190ddefc857cc78e6a58d36 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 8.74e-05 | 190 | 105 | 5 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 8.74e-05 | 190 | 105 | 5 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.89e-05 | 99 | 105 | 4 | 98c40a27432929434879c9e7283a14102f405f39 | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.89e-05 | 99 | 105 | 4 | d6bd8075dc7aba2034ea78b1389868282bc80a2d | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-05 | 191 | 105 | 5 | c21e7904e06a5c90176f935f6822dbb5a1aa6755 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.96e-05 | 191 | 105 | 5 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-ventral_progenitors_and_neurons_2|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 8.96e-05 | 191 | 105 | 5 | 509d17d8ee0d028757ce0f2c9b97e5875f06f0ab | |
| ToppCell | facs-Skin|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-05 | 191 | 105 | 5 | ae524103331fa53fa82888dbb567fc36abcee7e0 | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 8.96e-05 | 191 | 105 | 5 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 9.18e-05 | 192 | 105 | 5 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_3|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.18e-05 | 192 | 105 | 5 | d88753b200d9c8da6716222d697ddf0a1548d6c8 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-mature_NK_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.18e-05 | 192 | 105 | 5 | 189477c44040cf0ee16c3932fa49fbd9e3acaa3c | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.41e-05 | 193 | 105 | 5 | 6b3a2a32ec6dc96230cee4bbf03932f8a81e6683 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.41e-05 | 193 | 105 | 5 | b18c61e360f5f094f260007a56b189e2a48369e4 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-05 | 193 | 105 | 5 | 22ebc3f586eb0aabc5785e468c88d7416c624ff4 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.87e-05 | 195 | 105 | 5 | d32716a12014522492becbde1088dc1106308490 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD8-Trm/em_CD8|bone_marrow / Manually curated celltypes from each tissue | 9.87e-05 | 195 | 105 | 5 | ed4e2275dac47cc9fb9c381e3f80fed0ce50b074 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.87e-05 | 195 | 105 | 5 | 0a72b8446399807ace5b6c72f865bb40dbd9e92d | |
| ToppCell | Healthy/Control-CD8+_Tem|Healthy/Control / Disease group and Cell class | 9.87e-05 | 195 | 105 | 5 | f4955c176c4918052dc151c5e5249223ec428272 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.87e-05 | 195 | 105 | 5 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.87e-05 | 195 | 105 | 5 | b913d5df50c88a3a255f516a1aa42419c6701e1e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-04 | 196 | 105 | 5 | 7af6c5147ac859353504d19727dbe24f63a29dd4 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-PFC|World / Primary Cells by Cluster | 1.04e-04 | 197 | 105 | 5 | 2c3b0072f8e1e09c77a85c6fc3133d1796932fb2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-PFC-29|World / Primary Cells by Cluster | 1.04e-04 | 197 | 105 | 5 | c5bc0e7eb85642b270efc2ba92b13a736af22052 | |
| ToppCell | Multiple_Sclerosis-Myeloid-cDC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 1.06e-04 | 198 | 105 | 5 | ac139bfbf52b2feddb0c05b0708c8c9efbe119c9 | |
| ToppCell | control-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.06e-04 | 198 | 105 | 5 | 35499a5231818e3432cf69b5c4a58c02f7771db8 | |
| ToppCell | distal-1-Epithelial-Club|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.09e-04 | 199 | 105 | 5 | 8f0a72a95d0310ef2324c6975495c294b5a47cc8 | |
| ToppCell | distal-Epithelial-Club-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.09e-04 | 199 | 105 | 5 | 685cefbe6ff5db8b578e50b5849524ac2f347d0c | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.11e-04 | 200 | 105 | 5 | d0167f96314be78b6d867bbcc6e4396071d931b8 | |
| ToppCell | MS-Multiple_Sclerosis-Myeloid-cDC|Multiple_Sclerosis / Disease, condition lineage and cell class | 1.11e-04 | 200 | 105 | 5 | d9e6c344c59544c87bc13d1e866491da432c9c1b | |
| Drug | NSC35549 | 4.47e-08 | 22 | 104 | 5 | CID000411697 | |
| Drug | 2'-methoxyacetophenone | 9.26e-08 | 3 | 104 | 3 | CID000068481 | |
| Drug | BP-9,10-oxide | 1.35e-07 | 27 | 104 | 5 | CID000037456 | |
| Drug | Brn 4136738 | 1.35e-07 | 27 | 104 | 5 | CID000050331 | |
| Drug | C14845 | 1.35e-07 | 27 | 104 | 5 | CID011954064 | |
| Drug | 9-OH-BaP-4,5-oxide | 1.63e-07 | 28 | 104 | 5 | CID000115064 | |
| Drug | orphenadrine | 2.12e-07 | 56 | 104 | 6 | CID000004601 | |
| Drug | 19-hydroxytestosterone | 2.35e-07 | 30 | 104 | 5 | CID000150968 | |
| Drug | 11-H-14,15-EETA | 2.35e-07 | 30 | 104 | 5 | CID011954058 | |
| Drug | BP-7,8-oxide | 3.29e-07 | 32 | 104 | 5 | CID000037455 | |
| Drug | 12(13)-EpOME | 4.52e-07 | 34 | 104 | 5 | CID000001416 | |
| Drug | TCEO | 4.52e-07 | 34 | 104 | 5 | CID000028167 | |
| Drug | AC1O5XSP | 4.52e-07 | 34 | 104 | 5 | CID006442739 | |
| Drug | AC1L1CJI | 5.25e-07 | 35 | 104 | 5 | CID000001929 | |
| Drug | racemethorphan | 6.07e-07 | 107 | 104 | 7 | CID000003008 | |
| Drug | 15-H-11,12-EETA | 6.08e-07 | 36 | 104 | 5 | CID011954042 | |
| Drug | AC1L3NGJ | 6.08e-07 | 36 | 104 | 5 | CID000092121 | |
| Drug | 11,14,15-THET | 9.18e-07 | 39 | 104 | 5 | CID006439531 | |
| Drug | hydroxynefazodone | 9.34e-07 | 17 | 104 | 4 | CID000127096 | |
| Drug | debrisoquine | 1.22e-06 | 75 | 104 | 6 | CID000002965 | |
| Drug | 11,12,15-trihydroxyeicosatrienoic acid | 1.34e-06 | 42 | 104 | 5 | CID006439610 | |
| Drug | polybrominated biphenyl | 1.70e-06 | 44 | 104 | 5 | CID000042948 | |
| Drug | naphthalene-1,2-dihydrodiol | 1.91e-06 | 45 | 104 | 5 | CID000000362 | |
| Drug | C14802 | 2.38e-06 | 47 | 104 | 5 | CID011954053 | |
| Drug | nitro-L | 2.64e-06 | 48 | 104 | 5 | CID000006849 | |
| Drug | C14800 | 2.64e-06 | 48 | 104 | 5 | CID011954051 | |
| Drug | 19-HETE | 2.93e-06 | 49 | 104 | 5 | CID006439528 | |
| Drug | bromobenzene-3,4-oxide | 2.93e-06 | 49 | 104 | 5 | CID000108121 | |
| Drug | bromobenzene-2,3-oxide | 3.25e-06 | 50 | 104 | 5 | CID003036760 | |
| Drug | 6-hydroxymelatonin | 3.25e-06 | 50 | 104 | 5 | CID000001864 | |
| Drug | 1,1-dichloroethylene epoxide | 3.25e-06 | 50 | 104 | 5 | CID000119521 | |
| Drug | naphthalene epoxide | 3.59e-06 | 51 | 104 | 5 | CID000108063 | |
| Drug | 9-hydroxybenzo(a)pyrene | 4.35e-06 | 53 | 104 | 5 | CID000028598 | |
| Drug | paraxanthine | 4.35e-06 | 53 | 104 | 5 | CID000004687 | |
| Drug | dichloroacetaldehyde | 4.78e-06 | 54 | 104 | 5 | CID000006576 | |
| Drug | chloroacetyl chloride | 5.24e-06 | 55 | 104 | 5 | CID000006577 | |
| Drug | acetanilide | 5.73e-06 | 56 | 104 | 5 | CID000000904 | |
| Drug | 1,2-dihydroxynaphthalene | 6.26e-06 | 57 | 104 | 5 | CID000011318 | |
| Drug | bromoacetaldehyde | 6.82e-06 | 58 | 104 | 5 | CID000105131 | |
| Drug | Sparteinum | 7.01e-06 | 101 | 104 | 6 | CID000003966 | |
| Drug | encainide | 7.73e-06 | 28 | 104 | 4 | CID000048040 | |
| Drug | 1,1-dichloroethylene | 8.07e-06 | 60 | 104 | 5 | CID000006366 | |
| Drug | BP-4,5-oxide | 8.76e-06 | 61 | 104 | 5 | CID000037786 | |
| Drug | chlorzoxazone | 1.03e-05 | 63 | 104 | 5 | CID000002733 | |
| Drug | piperonyl butoxide | 1.39e-05 | 67 | 104 | 5 | CID000005794 | |
| Drug | propoxyphene | 1.39e-05 | 67 | 104 | 5 | CID000010100 | |
| Drug | sphondin | 1.49e-05 | 11 | 104 | 3 | CID000108104 | |
| Drug | 5,6-epoxyeicosatrienoic acid | 1.50e-05 | 68 | 104 | 5 | CID000001778 | |
| Drug | (Z) Fluvoxamine | 1.61e-05 | 69 | 104 | 5 | CID000003404 | |
| Drug | 8(9)-EET | 1.61e-05 | 69 | 104 | 5 | CID000001901 | |
| Drug | 1h1q | 1.73e-05 | 70 | 104 | 5 | CID000001540 | |
| Drug | 4-bromophenol | 1.73e-05 | 70 | 104 | 5 | CID000007808 | |
| Drug | 1,2-dibromoethane | 1.85e-05 | 71 | 104 | 5 | CID000007839 | |
| Drug | 16 alpha-hydroxytestosterone | 1.98e-05 | 12 | 104 | 3 | CID000065545 | |
| Drug | carteolol | 1.98e-05 | 72 | 104 | 5 | CID000002583 | |
| Drug | cupreidine | 2.07e-05 | 2 | 104 | 2 | CID000051196 | |
| Drug | propargyl ether | 2.07e-05 | 2 | 104 | 2 | ctd:C531209 | |
| Drug | Hempa | 2.07e-05 | 2 | 104 | 2 | ctd:D006492 | |
| Drug | nicotine imine | 2.07e-05 | 2 | 104 | 2 | ctd:C034629 | |
| Drug | alpha-nicotyrine | 2.07e-05 | 2 | 104 | 2 | ctd:C008615 | |
| Drug | 3-methoxyphenethylamine | 2.07e-05 | 2 | 104 | 2 | CID000074866 | |
| Drug | N-nitrosoguvacoline | 2.07e-05 | 2 | 104 | 2 | ctd:C036676 | |
| Drug | 2,2,2-trichloroethanol | 2.12e-05 | 73 | 104 | 5 | CID000008259 | |
| Drug | chloral | 2.12e-05 | 73 | 104 | 5 | CID000006407 | |
| Drug | atomoxetine | 2.16e-05 | 36 | 104 | 4 | CID000054840 | |
| Drug | S-oxalylglutathione | 2.56e-05 | 13 | 104 | 3 | CID000168007 | |
| Drug | Sordinol | 2.56e-05 | 13 | 104 | 3 | CID000012453 | |
| Drug | chloral hydrate | 2.84e-05 | 129 | 104 | 6 | CID000002707 | |
| Drug | C20H32O4 | 2.92e-05 | 78 | 104 | 5 | CID000001440 | |
| Drug | BP-7,8-diol | 2.92e-05 | 78 | 104 | 5 | CID000025892 | |
| Drug | Diethylstilbestrol [56-53-1]; Up 200; 15uM; PC3; HT_HG-U133A | 3.10e-05 | 194 | 104 | 7 | 3812_UP | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 3.20e-05 | 195 | 104 | 7 | 3620_UP | |
| Drug | N-nitrosomethylaniline | 3.25e-05 | 14 | 104 | 3 | CID000011957 | |
| Drug | trimipramine | 3.31e-05 | 80 | 104 | 5 | CID000005584 | |
| Drug | Trioxsalen [3902-71-4]; Up 200; 17.6uM; HL60; HT_HG-U133A | 3.41e-05 | 197 | 104 | 7 | 2516_UP | |
| Drug | Sertaconazole nitrate [99592-39-9]; Up 200; 8uM; PC3; HT_HG-U133A | 3.41e-05 | 197 | 104 | 7 | 4475_UP | |
| Drug | bupropion | 3.51e-05 | 81 | 104 | 5 | CID000000444 | |
| Drug | furafylline | 3.65e-05 | 41 | 104 | 4 | CID000003433 | |
| Drug | aminoglutethimide | 3.98e-05 | 137 | 104 | 6 | CID000002145 | |
| Drug | isopimpinellin | 4.05e-05 | 15 | 104 | 3 | CID000068079 | |
| Drug | aflatoxin Q1 | 4.05e-05 | 15 | 104 | 3 | CID000104757 | |
| Drug | 4-hydroxymephenytoin | 4.05e-05 | 15 | 104 | 3 | CID000119507 | |
| Drug | phenobarbital | 4.10e-05 | 360 | 104 | 9 | CID000004763 | |
| Drug | nefazodone | 4.42e-05 | 43 | 104 | 4 | CID000004449 | |
| Drug | Gemfibrozil | 4.43e-05 | 85 | 104 | 5 | ctd:D015248 | |
| Drug | diosmetin | 4.43e-05 | 85 | 104 | 5 | CID005281612 | |
| Drug | sulfaphenazole | 4.85e-05 | 44 | 104 | 4 | CID000005335 | |
| Drug | GW 6471 | 4.97e-05 | 16 | 104 | 3 | ctd:C449302 | |
| Drug | alpha-hydroxymetoprolol | 4.97e-05 | 16 | 104 | 3 | CID000114962 | |
| Drug | trichloroethylene | 5.23e-05 | 88 | 104 | 5 | CID000006575 | |
| Drug | mephenytoin | 5.23e-05 | 88 | 104 | 5 | CID000004060 | |
| Drug | 14(15)-EpETrE | 5.53e-05 | 89 | 104 | 5 | CID000001431 | |
| Drug | noralfentanil | 6.01e-05 | 17 | 104 | 3 | CID000162172 | |
| Drug | Methamphetamine | BCL9L CYP2D6 SOX18 ACOT1 GRIN2D GRM1 ARHGEF25 TAOK2 SRRT ADRA1B CITED4 TTLL4 PXN CTBP2 C1QTNF7 HDAC10 LTBP4 MN1 | 6.05e-05 | 1401 | 104 | 18 | ctd:D008694 |
| Drug | parathion | 6.15e-05 | 91 | 104 | 5 | CID000000991 | |
| Drug | 2,4,6-trimethylbenzaldoxime | 6.18e-05 | 3 | 104 | 2 | CID000283782 | |
| Drug | O-demethyl encainide | 6.18e-05 | 3 | 104 | 2 | CID000054736 | |
| Drug | chlorpromazine N-oxide | 6.18e-05 | 3 | 104 | 2 | CID000443037 | |
| Drug | sulfur | 6.67e-05 | 219 | 104 | 7 | CID000000402 | |
| Drug | tienilic acid | 6.82e-05 | 93 | 104 | 5 | CID000038409 | |
| Disease | dentatorubral-pallidoluysian atrophy (implicated_via_orthology) | 1.18e-05 | 2 | 102 | 2 | DOID:0060162 (implicated_via_orthology) | |
| Disease | solanidine measurement | 7.07e-05 | 4 | 102 | 2 | EFO_0800966 | |
| Disease | lobe attachment | 8.53e-05 | 207 | 102 | 6 | EFO_0007667 | |
| Disease | dodecadienoate (12:2) measurement | 1.18e-04 | 5 | 102 | 2 | EFO_0800572 | |
| Disease | X-16935 measurement | 2.46e-04 | 7 | 102 | 2 | EFO_0800763 | |
| Disease | X-24747 measurement | 3.27e-04 | 8 | 102 | 2 | EFO_0022135 | |
| Disease | X-17653 measurement | 4.19e-04 | 9 | 102 | 2 | EFO_0800783 | |
| Disease | melanoma-derived growth regulatory protein measurement | 6.38e-04 | 11 | 102 | 2 | EFO_0008229 | |
| Disease | nicotine metabolite ratio | 7.64e-04 | 12 | 102 | 2 | EFO_0007794 | |
| Disease | undecenoylcarnitine (C11:1) measurement | 9.00e-04 | 13 | 102 | 2 | EFO_0800588 | |
| Disease | Neoplastic Cell Transformation | 1.40e-03 | 139 | 102 | 4 | C0007621 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.64e-03 | 145 | 102 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | urinary metabolite measurement | 1.64e-03 | 245 | 102 | 5 | EFO_0005116 | |
| Disease | Feeding difficulties | 1.75e-03 | 18 | 102 | 2 | C0232466 | |
| Disease | caffeine metabolite measurement | 1.95e-03 | 19 | 102 | 2 | EFO_0007872 | |
| Disease | Lung diseases | 2.53e-03 | 78 | 102 | 3 | C0024115 | |
| Disease | unipolar depression, response to selective serotonin reuptake inhibitor | 3.11e-03 | 24 | 102 | 2 | EFO_0003761, EFO_0005658 | |
| Disease | non-high density lipoprotein cholesterol measurement | 3.34e-03 | 713 | 102 | 8 | EFO_0005689 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GPIKAYPRLGPPTPG | 236 | Q96PM9 | |
| GTLFLPPEPGPFPGI | 146 | Q86TX2 | |
| LPPGGFPAAVCPPGR | 191 | O95936 | |
| PCSPGPPGPVSGLRR | 66 | Q86VW2 | |
| RYPPGIVGVAPGGLP | 386 | P56545 | |
| TGPGFVPPPLAPIRG | 656 | Q96RT6 | |
| GKLPPGPTPLPFIGN | 31 | P11509 | |
| AGPEIGPSPAPPYGL | 516 | Q8IZ83 | |
| PLPAGPCLFGPPLAG | 176 | Q96IF1 | |
| PRPVLGGSFLGPPLP | 381 | Q9UK96 | |
| VCPPGAGGLPPPQRK | 1476 | O95477 | |
| GPPPPPPYGRLLANS | 441 | P54259 | |
| GLALQPGPPGLHPFP | 976 | P54259 | |
| VRGTLFLPPEPGPFP | 206 | P49753 | |
| PSPGYLGRGAPPPVE | 426 | P35368 | |
| ALGPVPPPGQPLLGS | 816 | Q96C12 | |
| GVPPPPGISLNLPYG | 611 | O60879 | |
| IVSTPPGGFPPPQGF | 266 | Q96EP5 | |
| LVPLGGFLQPPGGPL | 846 | Q149M9 | |
| GTLGPPPCQPPPGYA | 196 | Q9Y5P3 | |
| PATPYPLLFPPVIGG | 21 | P10826 | |
| LAPPPPPGLFFGLGS | 951 | Q68DA7 | |
| GIPAGFPAPRIGPQP | 941 | Q9H3S7 | |
| PPLGLPYPGPAGTRL | 571 | Q99742 | |
| YEGPPGAPRPLGSPL | 116 | Q5SZI1 | |
| LGPPFPGPPFSILSV | 256 | Q2Q1W2 | |
| PPNLPLGVPISSPGF | 246 | O95872 | |
| CPLPPGLLLPGYLGP | 616 | A4FU01 | |
| PPGFGGPRCRLPVPS | 1121 | Q5IJ48 | |
| LLPLCPGPGPGPGSE | 11 | Q8N158 | |
| SPGGPPLGLAPPPRY | 366 | Q14526 | |
| AGPLIVPYNLPLPGG | 111 | P17931 | |
| SPGLLGPALGPPYPS | 231 | Q6UXY1 | |
| GPALGPPYPSGRLTP | 236 | Q6UXY1 | |
| PPQGYFGPKLPPSLG | 1126 | Q9UKJ3 | |
| PAPPPISGGGYRARP | 61 | P02675 | |
| FGRVCLQPPGPPGSP | 331 | Q6ZS72 | |
| GPGPPGPCPTKRRLL | 231 | Q7L5A3 | |
| LLGPGALGLGPRPPP | 86 | Q9NP08 | |
| IPYAGAAAPPLPLPG | 366 | Q9UGU5 | |
| PVPGAYPNTGPGRRP | 241 | Q12950 | |
| GNPIRAYTPPPPLGP | 1156 | P42694 | |
| PVPSPLCPEPPGYTG | 576 | Q86Y91 | |
| PPGGSPYPASPLLGR | 366 | Q9BZI1 | |
| LYPPPPGLTEIPPGV | 156 | Q9UHB4 | |
| PPDCPVGGPLTFPGR | 176 | Q8NBZ0 | |
| PPLPGALSPLYGVPE | 171 | P49023 | |
| GVPKPGLYPLGPPSF | 1046 | O14559 | |
| GQYGQDLLIPPPPPG | 131 | Q5T0Z8 | |
| SGVFPGPGLGPNPRP | 226 | P0CG12 | |
| GRPPPLLPGGPVCKA | 376 | Q969S8 | |
| GEGRLPGTPPLFSPP | 306 | Q9C0K0 | |
| GKLPPGPTPLPFIGN | 31 | Q16696 | |
| PVLFPGQPFGQPPLG | 276 | Q16630 | |
| GKLPPGPTPLPFIGN | 31 | P20853 | |
| ARYPPGPLPLPGLGN | 31 | P10635 | |
| QLRGGPPFPGPRFPG | 591 | Q86UU0 | |
| FFIPPRLPDPGGAVP | 51 | B7Z1M9 | |
| GYVPGKVVPLRPPPP | 26 | Q9UHN6 | |
| PGCRGPPGSPVIRGP | 146 | P0C7T7 | |
| RPPAYSPPRPGGFGL | 1406 | Q8N2S1 | |
| PTYISPLGGGPGLPP | 546 | Q9Y6I3 | |
| FLLPVPGCPTGYLGP | 436 | Q68CP4 | |
| ALLQPPPPPGYGPSA | 186 | A6NMB9 | |
| PPYPLSQLPPGPSLG | 166 | Q8NBF1 | |
| GSPVPPIFGCRLPPP | 231 | Q9NVP4 | |
| SQTLGPAPLGPGPIP | 106 | O00321 | |
| GGPGNGLRSLYPPPP | 1056 | Q13255 | |
| PPPGLPCSGALRGFP | 376 | Q9H4Q3 | |
| PPAYATLGPRPSPGG | 641 | P37088 | |
| RYICSIPGLPGPPGP | 31 | Q9BXJ2 | |
| PPPPGGSGVLFRGPL | 666 | Q10571 | |
| GPLGPGAPPPLLFLN | 571 | Q16799 | |
| RLQPPPPLPFGLGGF | 76 | Q92733 | |
| TQYPPGRGTPPPPVG | 166 | P63162 | |
| PPIRYGPPPQLCGPF | 1781 | Q5JRA6 | |
| GPPPQLCGPFGPRPL | 1786 | Q5JRA6 | |
| LCGPFGPRPLPPPFG | 1791 | Q5JRA6 | |
| QEFRLPPPPGCPPGL | 876 | O15197 | |
| ESQRGPRGPYPPGPL | 21 | P02814 | |
| LFPPSLGLPPGPQPA | 326 | Q9H0F6 | |
| PLPPTLGPPLGGCVQ | 191 | B8ZZ34 | |
| LPIPGALGPPNTGTP | 756 | Q9UL54 | |
| GTPYPRDLPGAIPPP | 1496 | Q9P2R6 | |
| DQYLPLGGPAPPEPG | 286 | P57073 | |
| PAGLGPAQTPPYRPG | 216 | Q9ULL5 | |
| PGPAQILPPGLTPGL | 771 | Q9BXP5 | |
| GAVRPAVPTGGPPYP | 811 | Q9BXP5 | |
| ATLFLPPGPGPFPGI | 146 | Q8N9L9 | |
| LGPPPPRQPGALAYG | 51 | Q96RK1 | |
| ARYPPGPLPLPGLGN | 31 | A0A087X1C5 | |
| PYRGPGNPVPGPLAP | 6 | Q6P2Q9 | |
| GSGARPGVPLYPPGL | 236 | Q8IZ63 | |
| GGPGGGPLLPPRLLY | 136 | Q8N8E2 | |
| TAYPGLPGLPPVLLP | 3051 | Q86UP3 | |
| PGPISGPVQIPGPFR | 136 | Q8N7U7 | |
| GPVQIPGPFRGPIPG | 141 | Q8N7U7 | |
| PQSPPERRGYPGPGL | 1431 | Q7Z2Z1 | |
| PGPEPAGLGRRPCPY | 571 | Q9H1C4 | |
| VPLFQGPLPPPGSLG | 11 | Q12816 | |
| KPPRGILLYGPPGTG | 236 | P55072 | |
| SGQPPNPPGPLITGL | 601 | Q8TD17 | |
| ESQRGPRGPYPPGPL | 21 | Q99954 | |
| GRFPPPLSPPYGPGR | 61 | Q99954 | |
| GPTPPPFPGNRGTAL | 216 | O43516 | |
| YLPPVGPRPPKGFVG | 1546 | O00507 | |
| PGLPRPLGSFPCPTP | 651 | Q86UK7 | |
| TLGTPGPYPGPLSPP | 286 | P35713 | |
| GLPGIPRPTFPGAPG | 141 | P28347 | |
| GPPAGRAPAPLYVGP | 201 | Q64LD2 | |
| GLGPGLLGVPPQPAY | 66 | Q14679 | |
| PGSPPGALKQFLPPG | 46 | Q8TAS1 | |
| PPTPALGGQRGPPTC | 21 | Q6ZPA2 | |
| PPLLPGGAPLPAGLF | 291 | O15399 |